Literature DB >> 6658631

Sequential cervical specimens and the isolation of Chlamydia trachomatis: factors affecting detection.

J A Embil, H J Thiébaux, F R Manuel, L H Pereira, S W MacDonald.   

Abstract

For 260 consecutive patient visits by women to a clinic for sexually transmitted diseases, four cervical specimens were cultured in duplicate for detection of Chlamydia trachomatis. Sixty-one positive results were detected by at least one of the four specimens; the first two specimens detected 67-69% and the last two 80-82% of the 61 positives. The difference in these isolation rates is statistically significant (P = 0.003). Duplicate cultures of the same specimen did not significantly increase detection rates. A combination of two specimens could increase the number detected by 44.7% beyond the results of a single-specimen culture. Contamination rates were higher for the first two specimens. Routine cleaning of the cervical canal with a swab before the taking of specimens should reduce contamination and increase the probability of obtaining infected cells when they are present.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6658631     DOI: 10.1097/00007435-198304000-00003

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  19 in total

1.  Accuracy of two enzyme immunoassays and cell culture in the detection of Chlamydia trachomatis in low and high risk populations in Senegal.

Authors:  E Van Dyck; N Samb; A D Sarr; L Van de Velden; J Moran; S Mboup; I Ndoye; J L Lamboray; A Meheus; P Piot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

2.  Cervical specimen order and performance measures of Chlamydia trachomatis diagnostic testing.

Authors:  Khalil G Ghanem; Robert E Johnson; Emilia H Koumans; Jeanne M Marrazzo; Lauri E Markowitz
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Evaluation of a radioactive rRNA:cDNA-hybridisation assay for the direct detection of Chlamydia trachomatis in urogenital specimens.

Authors:  H Näher; B Niebauer; M Hartmann; J Söltz-Szöts; D Petzoldt
Journal:  Genitourin Med       Date:  1989-10

4.  Effect of endocervical specimen quality on detection of Chlamydia trachomatis and on the incidence of false-positive results with the Chlamydiazyme method.

Authors:  J A Kellogg; J W Seiple; C L Murray; J S Levisky
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

5.  Evaluation of three Chlamydia trachomatis immunoassays with an unbiased, noninvasive clinical sample.

Authors:  I D Paul; E O Caul
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

6.  Evidence of labile inhibitors in the detection of Chlamydia trachomatis in cervical specimens by polymerase chain reaction.

Authors:  A Clad; I Naudascher; U Flecken; H M Freidank; E E Petersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

7.  Comparison of three techniques for detection of Chlamydia trachomatis in endocervical specimens from asymptomatic women.

Authors:  J Lefebvre; H Laperrière; H Rousseau; R Massé
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

8.  Comparison of the Syva MicroTrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population.

Authors:  L M Clarke; M F Sierra; B J Daidone; N Lopez; J M Covino; W M McCormack
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

9.  Comparison of Gen-Probe DNA probe test and culture for the detection of Neisseria gonorrhoeae in endocervical specimens.

Authors:  E S Panke; L I Yang; P A Leist; P Magevney; R J Fry; R F Lee
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

10.  Quantitative culture of endocervical Chlamydia trachomatis.

Authors:  R C Barnes; B P Katz; R T Rolfs; B Batteiger; V Caine; R B Jones
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.